文献速递主动脉疾病

终末期肾病患者接受腹主动脉瘤腔内修复术后结局较差

Patients with end-stage renal disease have poor outcomes after endovascular abdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2018-06-23

基于血管质量倡议数据库2010至2017年28683例腹主动脉瘤腔内修复术(EVAR)患者,其中321例(1.12%)为透析依赖的终末期肾病(ESRD)患者。倾向性匹配和多因素分析显示,ESRD与30天死亡率(比值比4.1,95%CI 2.6-6.7,P<.001)和1年死亡率(风险比3.3,95%CI 2.5-4.2,P<.001)独立相关,尽管术后并发症无差异。

要点

  • ESRD透析患者EVAR后30天死亡率7% vs 非透析患者2.4%(P<.001)。
  • ESRD与30天死亡独立相关(OR 4.1,95%CI 2.6-6.7,P<.001)。
  • ESRD患者1年生存率78% vs 94%(P<.001),死亡风险HR 3.3(95%CI 2.5-4.2)。

核心结论

  • 在接受EVAR的患者中,ESRD独立关联较高的围手术期和1年死亡率,尽管与术后并发症增加无关。
  • 作者认为,在EVAR知情同意和风险获益考虑中应纳入此点,尤其对于择期修复。

研究设计与样本

  • 回顾性队列研究,查询血管质量倡议数据库2010至2017年所有接受EVAR的患者。
  • 比较ESRD透析患者与非透析患者,采用倾向性匹配评分和多因素分析分离ESRD效应。
  • 共识别28683例EVAR,其中321例(1.12%)为ESRD透析患者。

主要发现

  • ESRD患者就诊动脉瘤大小无差异(57.5±12.7 mm vs 56.7±17.2 mm;P=.44),但紧急/急诊修复更多(20.6% vs 13.6%;P=.002)。
  • 匹配后ESRD患者住院时间更长(4.8±9.4天 vs 4.1±12.6天;P=.026),30天死亡率更高(7% vs 2.4%;P<.001)。
  • 心脏、肺部、下肢、肠道和卒中并发症或重返手术室无差异。
  • 多因素分析中ESRD与30天死亡率相关(OR 4.1;95%CI 2.6-6.7;P<.001)。
  • 1年时ESRD透析患者生存更差(78% vs 94%;P<.001),ESRD与更高死亡率相关(HR 3.3;95%CI 2.5-4.2;P<.001)。

临床怎么用

  • 作者认为,在EVAR知情同意和风险获益考虑中应纳入ESRD独立关联高围手术期和1年死亡率这一信息,尤其对于择期修复。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although endovascular repair of abdominal aortic aneurysms (AAAs) has been demonstrated to have favorable outcomes, not all cohorts of patients with AAA fare equally well. Our goal was to investigate perioperative and 1-year outcomes in patients with end-stage renal disease (ESRD) on dialysis, who have traditionally fared worse after vascular interventions, to assess how ESRD affects outcomes in a large modern cohort of endovascular aneurysm repair (EVAR) patients. METHODS: The Vascular Quality Initiative database was queried for all patients undergoing EVAR from 2010 to 2017. ESRD patients were compared with patients not on dialysis. Propensity-matched scoring and multivariable analysis were used to isolate the effects of ESRD. RESULTS: Of 28,683 EVARs identified, there were 321 (1.12%) patients with ESRD on dialysis. Patients with ESRD had no difference in presenting AAA size (57.5 ± 12.7 mm vs 56.7 ± 17.2 mm; P = .44); however, they had more urgent/emergent repairs (20.6% vs 13.6%; P = .002) than those without ESRD. ESRD patients were more often younger, nonwhite, and nonobese and less likely to have commercial insurance (P < .05). ESRD patients more often had hypertension, coronary artery disease, congestive heart failure, previous lower extremity bypass, aneurysm repair, and carotid interventions (P < .05). There was no difference in the rate of concomitant procedures. Matching based on demographics, comorbidities, and operative details showed that ESRD patients had longer hospital length of stay (4.8 ± 9.4 days vs 4.1 ± 12.6 days; P = .026) and higher 30-day mortality (7% vs 2.4%; P < .001). There was no difference in cardiac, pulmonary, lower extremity, bowel, and stroke complications or return to the operating room. On multivariable analysis, ESRD was associated with 30-day mortality (odds ratio, 4.1; 95% confidence interval, 2.6-6.7; P < .001). Of the 24,750 elective EVARs, 1.04% had ESRD on dialysis. Matched data for elective EVAR show increased postoperative length of stay, hospital mortality, and 30-day mortality for ESRD patients on dialysis compared with those who are not. There was no association with postoperative myocardial infarction or pulmonary complications. At 1 year, patients with ESRD on dialysis had worse survival (78% vs 94%; P < .001), and ESRD was associated with higher mortality (hazard ratio, 3.3; 95% confidence interval, 2.5-4.2; P < .001). CONCLUSIONS: Among patients undergoing EVAR, ESRD is independently associated with higher perioperative and 1-year mortality despite not being associated with higher postoperative complications. This should be taken into account during informed consent for EVAR and risk-benefit considerations in this high-risk population, particularly for elective repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Komshian S, Farber A, Patel VI, et al. Patients with end-stage renal disease have poor outcomes after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2018. PMID: 29945838. doi:10.1016/j.jvs.2018.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。